Abnormal Liver Function Tests

Persistently abnormal LFTs in asymptomatic patients require a systematic approach to differential diagnosis. Start by repeating the LFT panel to confirm the abnormality and exclude pre-analytical errors. Consider the pattern of LFT elevation. A predominantly hepatocellular pattern (elevated AST and ALT) may suggest non-alcoholic fatty liver disease (NAFLD), viral hepatitis, or autoimmune hepatitis. A cholestatic pattern (elevated alkaline phosphatase and GGT) points towards biliary obstruction or cholestatic liver diseases like primary biliary cholangitis (PBC) or primary sclerosing cholangitis (PSC). Next, obtain a thorough medical history focusing on risk factors such as alcohol consumption, medication use, family history of liver disease, and travel history. Serological tests for viral hepatitis, autoimmune markers, and iron studies should be considered. Imaging studies, like abdominal ultrasound or MRI, can help assess liver morphology and identify structural abnormalities. If initial investigations are unrevealing, consider liver biopsy for a definitive diagnosis. Explore how specific LFT patterns combined with clinical findings can narrow the diagnostic possibilities and guide appropriate management. Always correlate laboratory findings with the patient's clinical picture.

While both NAFLD and AFLD present with elevated liver enzymes, differentiating them requires a thorough assessment of patient history and laboratory findings. Alcohol consumption is the key differentiator. Ask detailed questions about alcohol intake, including frequency, quantity, and duration. In NAFLD, patients typically have minimal to no alcohol consumption, while AFLD is associated with a history of chronic heavy alcohol use. LFTs may show a similar pattern of mild to moderate elevations in AST and ALT, often with AST/ALT ratio <1 in NAFLD and AST/ALT ratio >2 (although not always reliable) in AFLD. Elevated GGT and MCV can be suggestive of AFLD. Imaging studies, like ultrasound or MRI, can help evaluate the degree of steatosis and fibrosis but may not definitively differentiate between the two. A detailed dietary history and assessment for metabolic syndrome components (obesity, dyslipidemia, hypertension, and diabetes) are crucial in supporting the diagnosis of NAFLD. Consider implementing validated questionnaires to accurately assess alcohol consumption and learn more about the nuances of distinguishing NAFLD from AFLD based on clinical presentation.

Imaging studies play a crucial role in evaluating abnormal LFTs and guiding differential diagnosis. An abdominal ultrasound is often the initial imaging modality of choice due to its accessibility and cost-effectiveness. It can detect structural abnormalities like hepatomegaly, splenomegaly, fatty infiltration, and biliary dilatation, suggesting conditions like NAFLD, cirrhosis, or biliary obstruction. If ultrasound findings are inconclusive or a more detailed assessment of liver parenchyma is required, an MRI with or without contrast is recommended. MRI can better characterize focal liver lesions, assess the degree of fibrosis, and identify features suggestive of certain liver diseases, such as hemochromatosis or Wilson's disease. Consider imaging studies when LFT abnormalities persist despite initial investigations, when there are clinical signs or symptoms of liver disease, or when specific diagnoses are suspected based on the pattern of LFT elevation. Learn more about the strengths and limitations of different imaging modalities and how they can be integrated into the diagnostic algorithm for abnormal LFTs.